Sera Prognostics Insider Sale: 6,000 Shares Sold Under 10b5-1 Plan
Rhea-AI Filing Summary
Harrison Robert Gardner, Chief Information Officer of Sera Prognostics, Inc. (SERA), reported a sale of 6,000 shares of Class A common stock on 08/20/2025 under a pre-existing Rule 10b5-1 trading plan adopted May 21, 2025. The shares were sold at a weighted average price of $2.22, with executed prices ranging from $2.17 to $2.25. After the sales, the reporting person beneficially owned 102,577 shares directly. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on the same date.
Positive
- Sale executed under a Rule 10b5-1 trading plan, providing preplanned timing and reducing concerns about opportunistic insider trading.
- Clear pricing disclosure including weighted average price $2.22 and execution range $2.17–$2.25 enhances transparency.
- Form 4 filed by one reporting person with signature (attorney-in-fact) on the transaction date, indicating timely reporting.
Negative
- Insider reduced direct holdings by 6,000 shares, leaving 102,577 shares, a decrease of approximately 5.9% of the reporting person's post-transaction stake.
Insights
TL;DR Insider sale of ~6% of holdings executed under a 10b5-1 plan; transaction is transparent but reduces insider stake.
The sale of 6,000 shares represents approximately 5.9% of the reporting person's post-transaction direct holdings of 102,577 shares. Because the disposition was executed pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025, timing is preplanned rather than opportunistic. The weighted average sale price of $2.22 with execution prices between $2.17 and $2.25 provides clear pricing context. For investors, this is a routine insider liquidity event rather than an operational signal, though it modestly lowers the CIO's direct ownership stake.
TL;DR Pre-established trading plan mitigates governance concerns; disclosure is complete and conforms to Section 16 reporting.
The filing discloses a 10b5-1 plan and provides a weighted-average sale price plus the execution range and the plan adoption date, which are best practices for transparency. The Form 4 was signed by an attorney-in-fact and filed individually by the reporting person. There is no indication of derivative transactions or amendments. From a governance perspective, the disclosure reduces information asymmetry but highlights a modest reduction in insider ownership that governance stakeholders may note.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 6,000 | $2.22 | $13K |
Footnotes (1)
- The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.17 to $2.25, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
